280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
Investor Presentation
Reports Year End 2025 Financial Results and Highlights
Alumis Inc. Reports Preliminary Cash of $308.6 Million as of December 31, 2025
Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program
Other Events
Earnings Release
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report